Indraprastha Medical Corporation Limited (INDRAMEDCO.NS)
INR 500.05
(-0.28%)
INR 500.05
(-0.28%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 7.23 Billion INR | 30.28% |
| 2022 | 5.55 Billion INR | 20.24% |
| 2021 | 4.61 Billion INR | 6.89% |
| 2020 | 4.31 Billion INR | -3.79% |
| 2019 | 4.48 Billion INR | 6.3% |
| 2018 | 4.22 Billion INR | -3.17% |
| 2017 | 4.36 Billion INR | -11.27% |
| 2016 | 4.91 Billion INR | 5.41% |
| 2015 | 4.66 Billion INR | 1.63% |
| 2014 | 4.58 Billion INR | 2.26% |
| 2013 | 4.48 Billion INR | 2.44% |
| 2012 | 4.38 Billion INR | 8.99% |
| 2011 | 4.02 Billion INR | 12.27% |
| 2010 | 3.58 Billion INR | 19.28% |
| 2009 | 3 Billion INR | 5.98% |
| 2008 | 2.83 Billion INR | 4.43% |
| 2007 | 2.71 Billion INR | -1.89% |
| 2006 | 2.76 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2024 Q2 | 8.06 Billion INR | 0.0% |
| 2023 Q4 | 7.23 Billion INR | 0.0% |
| 2023 FY | 7.23 Billion INR | 30.28% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 6.67 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 5.55 Billion INR | 20.24% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 5.8 Billion INR | 0.0% |
| 2022 Q4 | 5.55 Billion INR | 0.0% |
| 2021 Q2 | 4.85 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 4.61 Billion INR | 6.89% |
| 2021 Q4 | 4.61 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 4.36 Billion INR | 0.0% |
| 2020 FY | 4.31 Billion INR | -3.79% |
| 2020 Q4 | 4.31 Billion INR | 0.0% |
| 2019 Q2 | 4.45 Billion INR | 0.0% |
| 2019 Q4 | 4.48 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 4.48 Billion INR | 6.3% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 4.22 Billion INR | -3.17% |
| 2018 Q4 | 4.22 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 4.45 Billion INR | 0.0% |
| 2017 FY | 4.36 Billion INR | -11.27% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q2 | 4.95 Billion INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q4 | 4.36 Billion INR | 0.0% |
| 2016 FY | 4.91 Billion INR | 5.41% |
| 2016 Q2 | 4.9 Billion INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q4 | 4.91 Billion INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q2 | 4.82 Billion INR | 0.0% |
| 2015 FY | 4.66 Billion INR | 1.63% |
| 2015 Q1 | - INR | -100.0% |
| 2015 Q4 | 4.66 Billion INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 FY | 4.58 Billion INR | 2.26% |
| 2014 Q4 | 4.58 Billion INR | 0.0% |
| 2014 Q2 | 4.62 Billion INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 FY | 4.48 Billion INR | 2.44% |
| 2013 Q4 | 4.48 Billion INR | 0.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q2 | 4.54 Billion INR | 0.0% |
| 2012 Q3 | - INR | -100.0% |
| 2012 Q2 | 8.63 Billion INR | 0.0% |
| 2012 FY | 4.38 Billion INR | 8.99% |
| 2012 Q4 | 4.38 Billion INR | 0.0% |
| 2011 FY | 4.02 Billion INR | 12.27% |
| 2010 FY | 3.58 Billion INR | 19.28% |
| 2009 FY | 3 Billion INR | 5.98% |
| 2008 FY | 2.83 Billion INR | 4.43% |
| 2007 FY | 2.71 Billion INR | -1.89% |
| 2006 FY | 2.76 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Apollo Hospitals Enterprise Limited | 167.53 Billion INR | 95.683% |
| Artemis Medicare Services Limited | 9.71 Billion INR | 25.555% |
| Aster DM Healthcare Limited | 179.91 Billion INR | 95.98% |
| Fortis Healthcare Limited | 132.88 Billion INR | 94.558% |
| HealthCare Global Enterprises Limited | 27.07 Billion INR | 73.288% |
| Krishna Institute of Medical Sciences Limited | 38.52 Billion INR | 81.224% |
| Lotus Eye Hospital and Institute Limited | 666.26 Million INR | -985.511% |
| Max Healthcare Institute Limited | 119.99 Billion INR | 93.973% |
| Max India Limited | 6.84 Billion INR | -5.684% |
| Global Health Limited | 43.04 Billion INR | 83.196% |
| Narayana Hrudayalaya Limited | 56.24 Billion INR | 87.141% |
| Rainbow Children's Medicare Limited | 21.7 Billion INR | 66.677% |
| Shalby Limited | 16.07 Billion INR | 55.009% |